Literature DB >> 8396673

Lymphocytes protect against and are not required for reovirus-induced myocarditis.

B Sherry1, X Y Li, K L Tyler, J M Cullen, H W Virgin.   

Abstract

Many studies suggest that host lymphocytes are damaging, rather than protective, in virally induced myocarditis. We have investigated the role of lymphocyte-based immunity in murine myocarditis by using a myocarditic reovirus (reovirus serotype 3 8B), nonmyocarditic reoviruses, adoptive transfer experiments, and mice with severe combined immunodeficiency (SCID mice). Prior to infection, passive transfer of monoclonal antibodies specific for 8B capsid proteins protected neonatal mice against 8B-induced myocarditis, indicating that humoral immunity can protect against myocarditis. Some monoclonal antibodies acted by blocking viral spread to and/or replication in the heart. Passive transfer of reovirus-immune, but not naive, spleen cells prior to infection protected neonatal mice from 8B-induced myocarditis. Depletion of either CD4 or CD8 T cells resulted in increased viral titer in the heart but did not abrogate immune cell-mediated protection against myocardial injury. This shows that both CD4 and CD8 T cells can act independently to protect myocardial tissue from reovirus infection. In addition, reovirus 8B caused extensive myocarditis in SCID mice. This confirms a prior report (B. Sherry, F. J. Schoen, E. Wenske, and B. N. Fields, J. Virol. 63:4840-4849, 1989) that T cells are not required for reovirus-induced myocarditis and demonstrates for the first time that B cells are not required for reovirus-induced myocarditis. We used SCID mice and a panel of reoviruses to assess (i) the relationship between growth in the heart and myocardial damage and (ii) the possibility that nonmyocarditic reoviruses exhibit a myocarditic phenotype in the absence of functional lymphocytes. Growth in the heart was not the sole determinant of myocarditic potential in SCID mice. Although 8B induced myocarditis in SCID mice, no or minimal myocarditis was found in SCID mice infected with four reovirus strains previously shown (B. Sherry and B. N. Fields, J. Virol. 63:4850-4856, 1989) to be nonmyocarditic or poorly myocarditic in normal neonatal mice. We conclude that (i) humoral immunity and cellular immunity are protective against, and not required for, reovirus-induced myocarditis and (ii) the potential to induce cardiac damage is a property of the virus independent of lymphocyte-based immunity.

Entities:  

Mesh:

Year:  1993        PMID: 8396673      PMCID: PMC238034     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  MURINE INFECTION WITH REOVIRUS. 3. PATHOLOGY OF INFECTION WITH TYPES 1 AND 2.

Authors:  M N WALTERS; P J LEAK; R A JOSKE; N F STANLEY; D H PERRET
Journal:  Br J Exp Pathol       Date:  1965-04

2.  The sequences of reovirus serotype 3 genome segments M1 and M3 encoding the minor protein mu 2 and the major nonstructural protein mu NS, respectively.

Authors:  J R Wiener; J A Bartlett; W K Joklik
Journal:  Virology       Date:  1989-04       Impact factor: 3.616

Review 3.  Autoimmune myocarditis: a paradigm of post-infection autoimmune disease.

Authors:  N R Rose; A Herskowitz; D A Neumann; N Neu
Journal:  Immunol Today       Date:  1988-04

Review 4.  Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens.

Authors:  J A Ledbetter; L A Herzenberg
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

5.  Murine natural killer cells limit coxsackievirus B3 replication.

Authors:  E K Godeny; C J Gauntt
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

6.  Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis.

Authors:  E K Godeny; C J Gauntt
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

7.  Pathogenesis of acute myocardial necrosis in inbred mice infected with coxsackievirus B3.

Authors:  J B Grun; M Schultz; S D Finkelstein; R L Crowell; B J Landau
Journal:  Microb Pathog       Date:  1988-06       Impact factor: 3.738

8.  Coxsackievirus B-3-induced myocarditis. Virus and actinomycin D treatment of myocytes induces novel antigens recognized by cytolytic T lymphocytes.

Authors:  S A Huber; N Heintz; R Tracy
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

Review 9.  Clinical and experimental aspects of viral myocarditis.

Authors:  K Leslie; R Blay; C Haisch; A Lodge; A Weller; S Huber
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

10.  Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis.

Authors:  L J Wolfgram; K W Beisel; N R Rose
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  34 in total

1.  Generating primary cultures of murine cardiac myocytes and cardiac fibroblasts to study viral myocarditis.

Authors:  Barbara Sherry
Journal:  Methods Mol Biol       Date:  2015

2.  Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice.

Authors:  J C Lenzo; G R Shellam; C M Lawson
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

3.  Spontaneous activation of a MAVS-dependent antiviral signaling pathway determines high basal interferon-β expression in cardiac myocytes.

Authors:  Efraín E Rivera-Serrano; Nicole DeAngelis; Barbara Sherry
Journal:  J Mol Cell Cardiol       Date:  2017-08-16       Impact factor: 5.000

4.  Organ-specific roles for transcription factor NF-kappaB in reovirus-induced apoptosis and disease.

Authors:  Sean M O'Donnell; Mark W Hansberger; Jodi L Connolly; James D Chappell; Melissa J Watson; Janene M Pierce; J Denise Wetzel; Wei Han; Erik S Barton; J Craig Forrest; Tibor Valyi-Nagy; Fiona E Yull; Timothy S Blackwell; Jeffrey N Rottman; Barbara Sherry; Terence S Dermody
Journal:  J Clin Invest       Date:  2005-08-11       Impact factor: 14.808

5.  Multiple viral core proteins are determinants of reovirus-induced acute myocarditis.

Authors:  B Sherry; M A Blum
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 6.  Apoptosis in animal models of virus-induced disease.

Authors:  Penny Clarke; Kenneth L Tyler
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

7.  Improved systemic delivery of oncolytic reovirus to established tumors using preconditioning with cyclophosphamide-mediated Treg modulation and interleukin-2.

Authors:  Timothy Kottke; Jill Thompson; Rosa Maria Diaz; Jose Pulido; Candice Willmon; Matt Coffey; Peter Selby; Alan Melcher; Kevin Harrington; Richard G Vile
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

Review 8.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

9.  Cytopathogenic effect in cardiac myocytes but not in cardiac fibroblasts is correlated with reovirus-induced acute myocarditis.

Authors:  C J Baty; B Sherry
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

10.  Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo.

Authors:  Roberta L DeBiasi; Bridget A Robinson; Barbara Sherry; Ron Bouchard; R Dale Brown; Mona Rizeq; Carlin Long; Kenneth L Tyler
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.